These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2009-013052-76 A single-arm, phase II study of SU11248 (sunitinib) in patients with von Hippel-Lindau (VHL) disease. 2011-03-28 due-trials
Not reported 2011-000882-11 A comparison of blood and tissue biomarkers before and after nephrectomy in the firstline setting with everolimus in patients with locally advanced or metastatic renal cell carcinoma Etude des marq... 2015-06-23 due-trials
Completed, but no date Terminated 2014-003774-16 Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride (XOFIGO®) in renal cell carcinoma patients with bone metastases Etude de phaseI/II de recherche de dose, d’évaluation de ... bad-data
Not reported 2016-001179-60 Randomized multicenter, phase III trial evaluating the safety of 2 schedules of cabazitaxel (bi-weekly versus tri-weekly) plus prednisone in elderly men (≥ 65 years) with metastatic castration-resista... 2023-04-06 due-trials
Other 2016-003099-28 A Phase 2 BIOmarker driven trial with Nivolumab and Ipilimumab or VEGFR tKi in naïve metastatic Kidney cancer Etude de phase II évaluant le Nivolumab avec ou sans l’Ipilimumab etun inhibiteur de ty... not-yet-due
Other 2021-003542-21 Evaluation of dAroLutamide Addition to anDrogen Deprivation therapy and radIatioN therapy in newly diagnosed prostate cancer with pelvic lymph nodes metastases Évaluation de l’ajout du darolutamide... not-yet-due